CHD7 regulates cardiovascular development through ATP-dependent and -independent activities.
Shun YanRassarin ThienthanasitDongquan ChenErik EngelenJoanna BrühlDavid K CrossmanRobert KestersonQin WangKarim BouazouneKai JiaoPublished in: Proceedings of the National Academy of Sciences of the United States of America (2020)
CHD7 encodes an ATP-dependent chromatin remodeling factor. Mutation of this gene causes multiple developmental disorders, including CHARGE (Coloboma of the eye, Heart defects, Atresia of the choanae, Retardation of growth/development, Genital abnormalities, and Ear anomalies) syndrome, in which conotruncal anomalies are the most prevalent form of heart defects. How CHD7 regulates conotruncal development remains unclear. In this study, we establish that deletion of Chd7 in neural crest cells (NCCs) causes severe conotruncal defects and perinatal lethality, thus providing mouse genetic evidence demonstrating that CHD7 cell-autonomously regulates cardiac NCC development, thereby clarifying a long-standing controversy in the literature. Using transcriptomic analyses, we show that CHD7 fine-tunes the expression of a gene network that is critical for cardiac NCC development. To gain further molecular insights into gene regulation by CHD7, we performed a protein-protein interaction screen by incubating recombinant CHD7 on a protein array. We find that CHD7 directly interacts with several developmental disorder-mutated proteins including WDR5, a core component of H3K4 methyltransferase complexes. This direct interaction suggested that CHD7 may recruit histone-modifying enzymes to target loci independently of its remodeling functions. We therefore generated a mouse model that harbors an ATPase-deficient allele and demonstrates that mutant CHD7 retains the ability to recruit H3K4 methyltransferase activity to its targets. Thus, our data uncover that CHD7 regulates cardiovascular development through ATP-dependent and -independent activities, shedding light on the etiology of CHD7-related congenital disorders. Importantly, our data also imply that patients carrying a premature stop codon versus missense mutations will likely display different molecular alterations; these patients might therefore require personalized therapeutic interventions.
Keyphrases
- genome wide
- mouse model
- newly diagnosed
- heart failure
- small molecule
- systematic review
- gene expression
- stem cells
- electronic health record
- pregnant women
- atrial fibrillation
- binding protein
- dna damage
- intellectual disability
- single cell
- oxidative stress
- induced apoptosis
- early onset
- signaling pathway
- autism spectrum disorder
- patient reported outcomes
- rna seq
- mass spectrometry
- high resolution
- bone marrow
- drug induced
- genome wide association